Cannapreneur Partners | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Headlines Articles Press releases Cannapreneur Partners

Home
Companies
Cannapreneur Partners

BRIEF

published on 02/21/2024 at 09:00, 9 months ago

TeamViewer Stands Out with an Excellent ESG Rating from Morningstar Sustainalytics

Sustainability ESG TeamViewer Sustainalytics Responsible Tech
PRESS RELEASE

published on 02/21/2024 at 09:00, 9 months ago

As of February 2024, TeamViewer receives a best-in-class in Morningstar Sustainalytics ESG Risk Rating
TeamViewer receives best-in-class ESG Risk Rating by Morningstar Sustainalytics in February 2024, demonstrating outstanding sustainability performance and commitment

Sustainability TeamViewer ESG Risk Rating Morningstar Sustainalytics Commitment
PRESS RELEASE

published on 02/07/2024 at 07:00, 9 months 14 days ago

TeamViewer delivers double-digit topline growth, strong margin, and 81% basic EPS increase
TeamViewer delivers strong financial results for FY 2023, with 11% revenue growth and 81% increase in basic EPS. The company also announces a share buyback program of up to EUR 150m for 2023/2024

Financial Results Revenue Growth Share Buyback Earnings Per Share TeamViewer
PRESS RELEASE

published on 10/31/2023 at 07:00, 1 year ago

TeamViewer with high 44% margin and 10% revenue growth in Q3 2023; on track to reach full year guidance
PRESS RELEASE

published on 10/25/2023 at 18:00, 1 year ago

TeamViewer SE: TeamViewer extends CEO contract with Oliver Steil through to 2028
PRESS RELEASE

published on 10/09/2023 at 08:00, 1 year 1 month ago

Samarkand Group plc : eCommerce Awards recognition
PRESS RELEASE

published on 09/28/2023 at 08:00, 1 year 1 month ago

Samarkand Group plc : Result of AGM
PRESS RELEASE

published on 09/13/2023 at 07:00, 1 year 2 months ago

TeamViewer SE: TeamViewer to reduce scope of Manchester United partnership effective from the start of the 2024/2025 season with significant positive effect on profitability
PRESS RELEASE

published on 09/01/2023 at 08:00, 1 year 2 months ago

Samarkand Group plc : Publication of Annual Report and Notice of AGM
PRESS RELEASE

published on 08/07/2023 at 08:00, 1 year 3 months ago

Samarkand Group plc : FY23 Results

Accesswire

Published on 11/21/2024 at 13:00, 33 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 33 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 33 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 33 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 33 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 17 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 57 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 18 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 26 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 32 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 35 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 13 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 48 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 48 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE